Canada markets closed

Orchard Therapeutics plc (ORTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4598+0.0198 (+4.50%)
At close: 04:00PM EST
0.4527 -0.01 (-1.54%)
After hours: 07:39PM EST
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
16,152
1,675
2,595
2,513
2,076
Cost of Revenue
4,338
226
857
805
422
Gross Profit
11,814
1,449
1,738
1,708
1,654
Operating Expenses
Research Development
91,648
86,977
93,730
117,363
205,319
Selling General and Administrative
51,744
54,905
64,986
57,218
31,366
Total Operating Expenses
143,392
141,882
158,716
174,581
236,685
Operating Income or Loss
-131,578
-140,433
-156,978
-172,873
-235,031
Interest Expense
2,829
2,497
2,328
1,538
-
Total Other Income/Expenses Net
-46,588
-1,238
3,411
7,211
5,506
Income Before Tax
-180,246
-143,756
-152,710
-165,662
-229,525
Income Tax Expense
-1,121
828
-731
-2,240
970
Income from Continuing Operations
-179,125
-144,584
-151,979
-163,422
-230,495
Net Income
-179,125
-144,584
-151,979
-163,422
-230,495
Net Income available to common shareholders
-179,125
-144,584
-151,979
-163,422
-230,495
Basic EPS
-
-0.29
-1.53
-1.75
-10.22
Diluted EPS
-
-0.29
-1.53
-1.75
-10.22
Basic Average Shares
-
127,519
99,446
93,240
22,559
Diluted Average Shares
-
127,519
99,446
93,240
22,559
EBITDA
-
-138,932
-148,378
-171,198
-233,832